Total Payments
$10,005
2024 Payments
$2,090
Companies
37
Transactions
491
Medicare Patients
13,166
Medicare Billing
$787,562
Payment Breakdown by Category
Food & Beverage$10,001 (100.0%)
Education$4.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,001 | 490 | 100.0% |
| Education | $4.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,791 | 108 | $0 (2024) |
| BIOTRONIK INC. | $1,105 | 23 | $0 (2019) |
| Abbott Laboratories | $918.93 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $724.81 | 42 | $0 (2024) |
| Amgen Inc. | $655.70 | 44 | $0 (2024) |
| Boston Scientific Corporation | $597.40 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $585.36 | 45 | $0 (2024) |
| PFIZER INC. | $531.82 | 34 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $467.52 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $390.32 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,090 | 104 | Novartis Pharmaceuticals Corporation ($447.72) |
| 2023 | $2,168 | 121 | Novartis Pharmaceuticals Corporation ($403.01) |
| 2022 | $1,824 | 84 | Novartis Pharmaceuticals Corporation ($376.48) |
| 2021 | $842.74 | 47 | Novartis Pharmaceuticals Corporation ($199.86) |
| 2020 | $413.75 | 17 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($146.35) |
| 2019 | $305.23 | 4 | BIOTRONIK INC. ($154.44) |
| 2018 | $758.53 | 20 | BIOTRONIK INC. ($412.49) |
| 2017 | $1,602 | 94 | BIOTRONIK INC. ($538.16) |
All Payment Transactions
491 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/13/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: Medical Device | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $10.78 | General |
| Category: Medical Device | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.59 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $36.83 | General |
| Category: Genetic Disease | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Neurology | ||||||
| 10/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Not Applicable | ||||||
| 10/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Genetic Disease | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.63 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,847 | 3,843 | $619,796 | $209,282 |
| 2022 | 34 | 3,116 | 4,101 | $612,303 | $203,448 |
| 2021 | 37 | 3,862 | 5,582 | $662,360 | $212,675 |
| 2020 | 34 | 3,341 | 4,273 | $519,007 | $162,157 |
Total Patients
13,166
Total Services
17,799
Medicare Billing
$787,562
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 693 | 1,196 | $253,289 | $106,452 | 42.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 141 | 142 | $69,656 | $19,485 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 197 | 229 | $33,110 | $13,679 | 41.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 90 | 90 | $39,208 | $10,962 | 28.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 189 | 191 | $33,998 | $9,719 | 28.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 140 | 140 | $48,440 | $7,764 | 16.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $13,545 | $4,922 | 36.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 27 | 94 | $6,698 | $4,064 | 60.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 54 | 71 | $10,058 | $3,692 | 36.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 407 | 486 | $21,964 | $2,741 | 12.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 61 | 106 | $7,526 | $2,161 | 28.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 16 | 17 | $5,967 | $2,045 | 34.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $5,540 | $1,906 | 34.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 74 | 125 | $8,250 | $1,792 | 21.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 30 | $4,470 | $1,785 | 39.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 14 | 14 | $4,665 | $1,724 | 37.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $5,291 | $1,607 | 30.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 145 | 145 | $9,425 | $1,486 | 15.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 133 | 157 | $1,823 | $1,311 | 71.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 16 | 59 | $3,363 | $1,185 | 35.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 43 | 47 | $4,512 | $1,166 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,474 | $937.75 | 37.9% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 58 | 60 | $2,940 | $921.20 | 31.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 38 | 43 | $1,147 | $838.50 | 73.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 14 | 90 | $2,070 | $684.84 | 33.1% |
About Dr. Terry Grainger, MD
Dr. Terry Grainger, MD is a Sleep Medicine healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003854464.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terry Grainger, MD has received a total of $10,005 in payments from pharmaceutical and medical device companies, with $2,090 received in 2024. These payments were reported across 491 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($10,001).
As a Medicare-enrolled provider, Grainger has provided services to 13,166 Medicare beneficiaries, totaling 17,799 services with total Medicare billing of $787,562. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Cardiovascular Disease
- Location Columbia, SC
- Active Since 06/04/2006
- Last Updated 09/30/2025
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1003854464
Products in Payments
- ENTRESTO (Drug) $1,218
- ELIQUIS (Drug) $866.43
- XARELTO (Drug) $585.36
- LEQVIO (Drug) $572.82
- Repatha (Biological) $536.90
- LifeVest (Device) $467.52
- JARDIANCE (Drug) $390.32
- VERQUVO (Drug) $374.24
- ONPATTRO (Drug) $343.88
- AVEIR (Device) $320.35
- VYNDAQEL (Drug) $267.20
- Confirm Rx (Device) $238.89
- WATCHMAN Access System (Device) $216.78
- (CK4) MCOT (Device) $215.89
- FARXIGA (Drug) $125.80
- CAMZYOS (Drug) $123.00
- GENERAL STENTS (Device) $118.83
- CONFIRM RX (Device) $118.26
- WATCHMAN (Device) $117.89
- BioMonitor 2 (Device) $117.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sleep Medicine Doctors in Columbia
Gibran Naddy, M.d, M.D
Sleep Medicine — Payments: $11,677
Sleep Medicine $11,677
Russell Ditzler, Md, MD
Sleep Medicine — Payments: $11,490
Sleep Medicine $11,490
Dr. Shaun Corbin, Md, MD
Sleep Medicine — Payments: $2,975
Sleep Medicine $2,975
Dr. Margaret Mike, M.d, M.D
Sleep Medicine — Payments: $2,651
Sleep Medicine $2,651
Antoinette Rutherford, M.d, M.D
Sleep Medicine — Payments: $318.76
Sleep Medicine $318.76
Dezmond Sumter
Sleep Medicine — Payments: $310.97
Sleep Medicine $310.97